Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
Stratta RJ, Alloway RR, Hodge E, Lo A; Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group. Stratta RJ, et al. Clin Transplant. 2002 Feb;16(1):60-8. doi: 10.1034/j.1399-0012.2002.00108.x. Clin Transplant. 2002. PMID: 11982617 Clinical Trial.
A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis.
Stratta RJ, Alloway RR, Hodge E, Lo A; Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group. Stratta RJ, et al. Transplant Proc. 2002 Aug;34(5):1903-5. doi: 10.1016/s0041-1345(02)03117-2. Transplant Proc. 2002. PMID: 12176622 Clinical Trial. No abstract available.
463 results